| Product Code: ETC11639983 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Chronic Myeloid Leukemia Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Chronic Myeloid Leukemia Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Chronic Myeloid Leukemia Market - Industry Life Cycle |
3.4 Israel Chronic Myeloid Leukemia Market - Porter's Five Forces |
3.5 Israel Chronic Myeloid Leukemia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Chronic Myeloid Leukemia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Chronic Myeloid Leukemia Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Chronic Myeloid Leukemia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia in Israel |
4.2.2 Advances in medical research leading to improved treatment options |
4.2.3 Growing awareness and early detection of the disease |
4.3 Market Restraints |
4.3.1 High cost of chronic myeloid leukemia treatments |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
4.3.3 Regulatory challenges impacting drug approvals and market access |
5 Israel Chronic Myeloid Leukemia Market Trends |
6 Israel Chronic Myeloid Leukemia Market, By Types |
6.1 Israel Chronic Myeloid Leukemia Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Tyrosine Kinase Inhibitors (TKIs), 2021 - 2031F |
6.1.4 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Stem Cell Transplant, 2021 - 2031F |
6.2 Israel Chronic Myeloid Leukemia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Israel Chronic Myeloid Leukemia Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Israel Chronic Myeloid Leukemia Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
7 Israel Chronic Myeloid Leukemia Market Import-Export Trade Statistics |
7.1 Israel Chronic Myeloid Leukemia Market Export to Major Countries |
7.2 Israel Chronic Myeloid Leukemia Market Imports from Major Countries |
8 Israel Chronic Myeloid Leukemia Market Key Performance Indicators |
8.1 Average age of diagnosis of chronic myeloid leukemia patients in Israel |
8.2 Number of clinical trials for new treatments conducted in Israel |
8.3 Adoption rate of novel therapies for chronic myeloid leukemia in Israel |
9 Israel Chronic Myeloid Leukemia Market - Opportunity Assessment |
9.1 Israel Chronic Myeloid Leukemia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Chronic Myeloid Leukemia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Chronic Myeloid Leukemia Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Chronic Myeloid Leukemia Market - Competitive Landscape |
10.1 Israel Chronic Myeloid Leukemia Market Revenue Share, By Companies, 2024 |
10.2 Israel Chronic Myeloid Leukemia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here